Netcall (LON:NET – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Berenberg Bank in a research report issued on Wednesday, October 7th, Digital Look reports. They currently have a GBX 165 price target on the stock. Berenberg Bank’s price objective indicates a potential upside of 27.02% from the company’s current price.
Separately, Canaccord Genuity Group reissued a “buy” rating and issued a GBX 160 price target on shares of Netcall in a research note on Thursday, September 10th. Two equities research analysts have rated the stock with a Buy rating. According to data from MarketBeat, Netcall has a consensus rating of “Buy” and a consensus price target of GBX 167.50.
View Our Latest Research Report on NET
Netcall Price Performance
Shares of Netcall stock traded up GBX 2.90 on Wednesday, hitting GBX 129.90. 747,223 shares of the company traded hands, compared to its average volume of 374,416. The company has a current ratio of 0.65, a quick ratio of 0.88 and a debt-to-equity ratio of 1.82. The firm’s 50-day simple moving average is GBX 120.33 and its 200 day simple moving average is GBX 118.19. Netcall has a 12-month low of GBX 94.10 and a 12-month high of GBX 138. The company has a market cap of £221.61 million, a P/E ratio of 91.48 and a beta of 0.11.
Netcall (LON:NET – Get Free Report) last posted its quarterly earnings data on Wednesday, October 7th. The company reported GBX 4.39 earnings per share (EPS) for the quarter. Netcall had a return on equity of 3.23% and a net margin of 2.72%. Analysts expect that Netcall will post 3.70 earnings per share for the current fiscal year.
About Netcall
Netcall is a UK-based enterprise software company that unites automation and customer engagement in one AI-powered platform. Its Liberty platform makes work easier by digitising processes and simplifying customer interactions in a single, easy-to-use solution that reduces complexity. Today, around 600 organisations across healthcare, government and financial services rely on Netcall for mission?critical workflows, including two?thirds of NHS Acute Health Trusts and major enterprises such as Legal & General, Baloise and Santander.
See Also
- Five stocks we like better than Netcall
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for Netcall Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Netcall and related companies with MarketBeat.com's FREE daily email newsletter.
